About AbbVie Inc. (ABBV)
AbbVie Inc. is a Drug Manufacturers - General company operating in the Healthcare sector.
ABBV trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $204.93
- Market Cap
- $362.35B
- 52-Week High
- $244.81
- 52-Week Low
- $164.39
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
$1,000 Invested in AbbVie Inc. (ABBV)
How much would $1,000 invested in ABBV be worth today?
What would $1,000 invested in ABBV 1 year ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2025 would be worth $1,009 as of May 2026, representing a +0.8% total return.
What would $1,000 invested in ABBV 3 years ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2023 would be worth $1,481 as of May 2026, representing a +48.1% total return.
What would $1,000 invested in ABBV 5 years ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2021 would be worth $2,362 as of May 2026, representing a +136.2% total return.
What would $1,000 invested in ABBV 10 years ago be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) in 2016 would be worth $5,571 as of May 2026, representing a +457.1% total return.
What would $1,000 invested in ABBV at IPO be worth today?
A $1,000 investment in AbbVie Inc. (ABBV) at IPO would be worth $9,885 as of May 2026, representing a +888.5% total return.
DCA vs Lump Sum Calculator
Compare dollar-cost averaging vs lump sum investing strategies for ABBV
ABBV vs S&P 500
See how ABBV compares to the S&P 500 benchmark over time
Monthly Returns Heatmap
Over the past 13+ years (158 months), AbbVie Inc. (ABBV) has averaged a monthly return of +1.68% with a median return of +1.48%. The stock had 97 positive months (61%) and 60 negative months (38%). The best month in ABBV's history was November 2020 with a +22.9% return, while the worst was March 2018 at -18.3%. Historically, November tends to be the strongest month (averaging +6.4%), and January the weakest (-1.7%).
ABBV's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 2017 with a cumulative return of +49.7%, and the worst was 2015 at -3.6%.
Annual Returns
Over 13 years of trading history, AbbVie Inc. (ABBV) has delivered an average annual return of +16.77% with a median return of +18.86%. The compound annual growth rate (CAGR) is +15.24%. The stock posted gains in 9 years (69%) and losses in 4 years (31%).
ABBV's best year was 2017 with a +60.07% gain, while the worst was 2026 at -9.59%. The longest streak of consecutive positive years was 4, and the longest losing streak was 1 years. ABBV achieved double-digit gains (10%+) in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -9.59% | $226.67 | $204.93 |
| 2025 | +33.08% | $170.33 | $226.67 |
| 2024 | +18.86% | $143.30 | $170.33 |
| 2023 | -0.23% | $143.64 | $143.30 |
| 2022 | +24.01% | $115.83 | $143.64 |
| 2021 | +32.43% | $87.47 | $115.83 |
| 2020 | +27.72% | $68.48 | $87.47 |
| 2019 | +1.47% | $67.49 | $68.48 |
| 2018 | -0.96% | $68.15 | $67.49 |
| 2017 | +60.07% | $42.57 | $68.15 |
| 2016 | +9.79% | $38.77 | $42.57 |
| 2015 | -6.50% | $41.47 | $38.77 |
| 2014 | +27.92% | $32.42 | $41.47 |
Frequently Asked Questions: ABBV
What sector is ABBV in? ▼
ABBV operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has ABBV performed historically? ▼
Over 13 years of trading history, ABBV has posted gains in 9 years (69% of the time). The best year was 2017 with a +60.1% return. Past performance does not guarantee future results.
How can I invest in ABBV? ▼
You can invest in ABBV through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold ABBV.
Last updated: 3/24/2026